Breaking News

Comar To Sell Glass Manufacturing Operation

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Comar, Inc. has plans to sell its glass manufacturing operation, with the exception of its glass pipette manufacturing business, to Gerresheimer’s Kimble Glass, Inc. Terms of the agreement were not disclosed. The closing of the transaction is expected by end of this month.

The transaction includes real estate, manufacturing equipment, plant operations and management personnel. Comar’s glass pipette manufacturing equipment and associated operating personnel will be relocated to the company’s plastic operations in Buena, NJ. The full transition of the glass operation to Kimble is expected to take place within six months.

Henry Tamagni, Jr., president and chief executive officer of Comar, commented, “We appreciate all of the wonderful relationships we have developed over the years in the glass industry and, the loyalty and devotion of our workforce. We are confident that Kimble will maintain the same attention to quality and responsiveness that has been a Comar trademark, and that the same talented and professional workforce will continue to serve its customers as they have for so many years.”

According to Mike Ruggieri, Comar’s general manager, “The sale of the glass division is the first step of a multi-year strategy to refocus Comar’s resources on dramatic growth in the pharmaceutical and health care plastics packaging industry. We intend to expand our presence through the addition of new and innovative plastics solutions while maintaining our leading market share in glass and plastic dropper assemblies.”

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters